Life Extension Magazine December 2004
by Heather S. Oliff, PhD
By Heather S. Oliff, PhD
|LE Magazine December 2004|
|Flower Pollen |
Powerful Protection for Prostate Health
by Heather S. Oliff, PhD
Other Beneficial Phytotherapeutics
Over all, the clinical studies concluded that saw palmetto improves symptoms of benign prostatic hyperplasia, including urinary flow rate, nocturia, painful urination, residual urine, and inflammation.17 Saw palmetto may produce its effect by lowering levels of DHT in prostate tissue. Animal studies demonstrate that saw palmetto induces apoptosis (programmed cell death), inhibits cell proliferation, and prohibits the action of estrogen in the prostate.17 Saw palmetto is well tolerated, though gastrointestinal disturbance has been reported in rare cases.17
Omega-3 Fatty Acids (Fish Oils)
A low-fat diet supplemented with omega-3 fatty acids from fish oil may prevent the development and progression of prostate cancer and possibly benign prostatic hyperplasia by altering COX-2 expression and prostaglandin production in prostatic tissue.19 COX-2 is an enzyme that converts omega-6 fatty acids to prostaglandins, which stimulate inflammation and the growth of new blood vessels to feed a growing tumor. The potential for omega-3 fatty acids contained in fish oils to prevent benign prostatic hyperplasia and prostate cancer requires further study, but the preliminary evidence is encouraging.
Lycopene’s antioxidant activity is at least twice as great as that of beta-carotene. Extensive scientific evidence demonstrates that increased consumption of tomato products and other lycopene-containing foods may reduce the occurrence or progression of prostate cancer.27 Scientists evaluating 1,872 men with and without prostate cancer discovered that there is a lower risk of prostate cancer in men with higher plasma levels of lycopene.27 In a smaller study, scientists found that consuming tomato sauce entrees (containing 30 mg of lycopene daily) increased apoptosis in benign prostatic hyperplasia cells.28 Additional large-scale studies are needed to confirm this exciting finding.
Considering that the precise cause of benign prostatic hyperplasia remains unknown, it stands to reason that a product such as Cernitin®, which contains several phytotherapies with various mechanisms of action, may be the most effective way to both prevent and treat benign prostatic hyperplasia. With its demonstrated benefits and lack of side effects, Cernitin® is an important addition to the arsenal of products for prostate health.
1. Prostate Enlargement: Benign Prostatic Hyperplasia: National Kidney and Urologic Diseases Information Clearinghouse; February 2004. NIH Publication No. 04-3012.
2. Skolarikos A, Thorpe AC, Neal DE. Lower urinary tract symptoms and benign prostatic hyperplasia. Minerva Urol Nefrol. 2004 Jun;56(2):109-22.
3. Wilt TJ, Ishani A, Rutks I, MacDonald R. Phytotherapy for benign prostatic hyperplasia. Public Health Nutr. 2000 Dec;3(4A):459-72.
4. Available at: http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/flo_0108.shtml. Accessed September 9, 2004.
5. Nakase S, Takenaka K, Hamanaka T, Kimura M. Effects of Cernilton pollen-extract on urethral smooth muscle and diaphragmatic neuromuscular specimen. Folio Pharmacol Jpn. 1988;91:385-92.
6. Ito R, Ishii M, S. Y, et al. Antiprostatic hypertrophic action of Cernilton pollen-extract. Pharmacometrics. 1986;31:1-11.
7. Kimura M, Kimura I, Nakase K, Sonobe T, Mori N. Micturition activity of pollen extract: contractile effects on bladder and inhibitory effects on urethral smooth muscle of mouse and pig. Planta Med. 1986 Apr;(2):148-51.
8. Loschen G, Ebeling L. Inhibition of arachidonic acid cascade by extract of rye pollen. Arzneimittelforschung. 1991 Feb;41(2):162-7.
9. Available at: http://www.graminex.com/clinical_studies/study7.htm. Accessed September 13, 2004.
10. Tunn S, Krieg M. Hormone metabolism in the human prostate. In: Vahlensieck W, Rutishauser G, eds. Benign Prostate Diseases. New York, NY: Thieme Medical Publishers, Inc.; 1992:17-21.
11. Available at: http://www.graminex.com/clinical_studies/study8.htm. Accessed September 13, 2004.
12. Dutkiewicz S. Usefulness of Cernilton in the treatment of benign prostatic hyperplasia. Int Urol Nephrol. 1996;28(1):49-53.
13. Yasumoto R, Kawanishi H, Tsujino T, et al. Clinical evaluation of long-term treatment using cernitin pollen extract in patients with benign prostatic hyperplasia. Clin Ther. 1995 Jan-Feb;17(1):82-7.
14. Buck AC, Cox R, Rees RW, Ebeling L, John A. Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract, cernilton. A double-blind, placebo-controlled study. Br J Urol. 1990 Oct;66(4):398-404.
15. Available at: http://www.graminex.com/clinical_studies/study83.php. Accessed September 9, 2004.
16. Habib FK, Ross M, Buck AC, Ebeling L, Lewenstein A. In vitro evaluation of the pollen extract, cernitin T-60, in the regulation of prostate cell growth. Br J Urol. 1990 Oct;66(4):393-7.
17. Blumenthal M, ed. The ABC Clinical Guide to Herbs. Austin, TX: American Botanical Council; 2003.
18. Terry P, Lichtenstein P, Feychting M, Ahlbom A, Wolk A. Fatty fish consumption and risk of prostate cancer. Lancet. 2001 Jun 2;357(9270):1764-66.
19. Aronson WJ, Glaspy JA, Reddy ST, Reese D, Heber D, Bagga D. Modulation of omega-3/omega-6 polyunsaturated ratios with dietary fish oils in men with prostate cancer. Urology. 2001 Aug;58(2):283-8.
20. Blumenthal M, Goldberg A, Brinckmann J, eds. Herbal Medicine. Expanded Commission E Monographs. 1st ed. Newton, MA: Integrative Medicine Communications; 2000.
21. Hryb DJ, Khan MS, Romas NA, Rosner W. The effect of extracts of the roots of the stinging nettle (Urtica dioica) on the interaction of SHBG with its receptor on human prostatic membranes. Planta Med. 1995 Feb;61(1):31-2.
22. Ding VD, Moller DE, Feeney WP, et al. Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway. Endocrinology. 1998 Jan;139(1):213-8.
23. Wilt TJ, Ishani A, Mac Donald R, Rutks I, Stark G. Pygeum africanum for benign prostatic hyperplasia (Cochrane Review). The Cochrane Library. Vol Issue 3. Chichester, UK: John Wiley & Sons, Ltd.; 2004.
24. Santa Maria Margalef A, Paciucci Barzanti R, Reventos Puigjaner J, Morote Robles J, Thomson Okatsu TM. Antimitogenic effect of Pygeum africanum extracts on human prostatic cancer cell lines and explants from benign prostatic hyperplasia. Arch Esp Urol. 2003 May;56(4):369-78.
25. Singletary K, MacDonald C, Wallig M. Inhibition by rosemary and carnosol of 7,12-dimethylbenz[a]anthracene (DMBA)-induced rat mammary tumorigenesis and in vivo DMBA-DNA adduct formation. Cancer Lett. 1996 Jun 24;104(1):43-8.
26. Minnunni M, Wolleb U, Mueller O, Pfeifer A, Aeschbacher HU. Natural antioxidants as inhibitors of oxygen species induced mutagenicity. Mutat Res. 1992 Oct;269(2):193-200.
27. Gann PH, Ma J, Giovannucci E, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999 Mar 15;59(6):1225-30.
28. Kim HS, Bowen P, Chen L, et al. Effects of tomato sauce consumption on apoptotic cell death in prostate benign hyperplasia and carcinoma. Nutr Cancer. 2003;47(1):40-7.
29. Available at: http://www.graminex.com/clinical_studies/study22.php. Accessed September 15, 2004.